Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oropharynx Squamous Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02381535
What this trial is testing

Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin

Who this might be right for
Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7+9 more
National Cancer Institute (NCI) 2
Large-scale testing (Phase 3)Study completedNCT00162708
What this trial is testing

Very Intense Radiotherapy-chemotherapy Regimen in Advanced HNSCC

Who this might be right for
Oropharynx CancerOral CancerHypopharynx Cancer+1 more
Gustave Roussy, Cancer Campus, Grand Paris 120
Not applicableStudy completedNCT01358097
What this trial is testing

Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy

Who this might be right for
Head and Neck CancerOropharyngeal CancerHuman Papillomavirus+1 more
Icahn School of Medicine at Mount Sinai 33
Large-scale testing (Phase 3)Looking for participantsNCT05333523
What this trial is testing

Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Study.

Who this might be right for
Laryngeal Squamous Cell CarcinomaHypopharynx Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma
Radboud University Medical Center 242
Testing effectiveness (Phase 2)Active Not RecruitingNCT04609280
What this trial is testing

Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110)

Who this might be right for
Head and Neck CancerOropharynx CancerOropharyngeal Squamous Cell Carcinoma
University of Maryland, Baltimore 52
Not applicableStudy completedNCT06701058
What this trial is testing

Active MMP-8 in Oral Fluid for the Detection of Oral and Oropharyngeal Cancer

Who this might be right for
Oropharyngeal CancersBiomarker in Early DiagnosisOral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer+1 more
Helsinki University Central Hospital 107
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07578467
What this trial is testing

Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs

Who this might be right for
HPV Positive Oropharyngeal Squamous Cell CarcinomaSquamous Cell CarcinomaHPV (Human Papillomavirus)-Associated Carcinoma+2 more
Abramson Cancer Center at Penn Medicine 35
Testing effectiveness (Phase 2)Ended earlyNCT03618134
What this trial is testing

Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Participants With Human Papillomavirus Positive Oropharyngeal Squamous Cell Caner

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC (American Joint Committee on Cancer) v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+6 more
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT00898664
What this trial is testing

DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 74
Testing effectiveness (Phase 2)Looking for participantsNCT06448026
What this trial is testing

Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Locally Recurrent Oral Cavity Squamous Cell Carcinoma
M.D. Anderson Cancer Center 17
Not applicableEnded earlyNCT02388932
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma+25 more
Case Comprehensive Cancer Center 3
Not applicableStudy completedNCT00291434
What this trial is testing

Altered and Conventional Fractionated Radiotherapy in Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Institute of Radiotherapy and Oncology, Macedonia 152
Not applicableStudy completedNCT01015963
What this trial is testing

Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 69
Early research (Phase 1)Ended earlyNCT03809624
What this trial is testing

Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer

Who this might be right for
Metastatic Solid TumorsNon-small Cell Lung CancerMelanoma+6 more
Inhibrx Biosciences, Inc 160
Testing effectiveness (Phase 2)Study completedNCT03067610
What this trial is testing

Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerCarcinoma, Squamous CellNeoplasms, Oral+1 more
University of Texas Southwestern Medical Center 72
Testing effectiveness (Phase 2)UnknownNCT03669718
What this trial is testing

Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC

Who this might be right for
Squamous Cell Carcinoma of the OropharynxHPV16 Positive
ISA Pharmaceuticals 194
Testing effectiveness (Phase 2)Study completedNCT01932697
What this trial is testing

Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer

Who this might be right for
Human Papillomavirus InfectionStage I Oropharyngeal Squamous Cell CarcinomaStage II Oropharyngeal Squamous Cell Carcinoma+3 more
Mayo Clinic 81
Testing effectiveness (Phase 2)Looking for participantsNCT06563362
What this trial is testing

Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck Squamous Cell Carcinoma

Who this might be right for
Oropharynx Cancer
University of Zurich 120
Testing effectiveness (Phase 2)Study completedNCT00003657
What this trial is testing

High-dose ICE With Amifostine

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsCarcinoma of Unknown Primary+8 more
Dana-Farber Cancer Institute 24
Testing effectiveness (Phase 2)Study completedNCT00055913
What this trial is testing

Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity+10 more
National Cancer Institute (NCI) 58
Next Page
19